Methyljasmonate displaysin vitroandin vivoactivity against multiple myeloma cells

Metabolic Reprogramming: A Cancer Hallmark Even Warburg Did Not Anticipate

(2012) Patrick S. Ward et al.   CANCER CELL

Tumor cell-specific bioluminescence platform to identify stroma-induced changes to anticancer drug activity

(2010) Douglas W McMillin et al.   NATURE MEDICINE

Steroid Hormone Transforming Aldo-Keto Reductases and Cancer

(2009) Trevor M. Penning et al.   Annals of the New York Academy of Sciences

AKR1C Isoforms Represent a Novel Cellular Target for Jasmonates alongside Their Mitochondrial-Mediated Effects

(2009) N. J. Davies et al.   CANCER RESEARCH

Methyl jasmonate downregulates expression of proliferating cell nuclear antigen and induces apoptosis in human neuroblastoma cell lines

(2008) Qiang-Song Tong et al.   ANTI-CANCER DRUGS

Methyl jasmonate induces cell death with mixed characteristics of apoptosis and necrosis in cervical cancer cells

(2008) Tatiana Kniazhanski et al.   CANCER LETTERS

Methyl jasmonate binds to and detaches mitochondria-bound hexokinase

(2008) N Goldin et al.   ONCOGENE